相关实验视频
Updated: Jul 19, 2025

Isolation of CD133+ Liver Stem Cells for Clonal Expansion
Published on: October 10, 2011
在肝细胞癌干细胞中,SETD1A通过重新编程表观遗传景观来驱动干细胞
Jianxu Chen1,2,3, Zhijie Xu1,2, Hongbin Huang1,2
1Guangdong Provincial Engineering Research Center of Molecular Imaging.
含有1A (SETD1A) 的SET域驱动肝细胞癌 (HCC) 的癌症干. 这种表观遗传调节器激活瘤基因并禁用瘤抑制剂,为HCC干预提供了潜在的治疗标.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
- 肝细胞癌研究 肝细胞癌研究
背景情况:
- 癌症干细胞 (CSCs) 在肝细胞癌 (HCC) 中驱动瘤进展和复发.
- 调节HCC干性的机制尚未完全理解.
- SETD1A是一种涉及表观遗传调节的H3K4甲基转移酶.
研究的目的:
- 为了确定肝细胞癌 (HCC) 干的关键调节者.
- 阐明含有1A (SETD1A) 的SET域在HCC干和进展中的作用.
- 评估SETD1A作为HCC的潜在治疗点.
主要方法:
- 在HCC细胞中基因组规模的CRISPR淘汰屏幕.
- 对SETD1A表达与临床结果的相关性分析.
- 评估SETD1A在表观遗传修饰和基因表达中的作用.
- 调查SETD1A与多基酸结合蛋白细胞质1的合作.
主要成果:
- 鉴定出SETD1A是HCC.癌细胞干的驱动因素.
- SETD1A表达与不良的临床结果相关,并预测HCC复发.
- 通过基因组修饰,SETD1A调解瘤基因的转录激活和瘤抑制基因的失活.
- SETD1A与PABPC1合作,在瘤基因上调节H3K4me3.
结论:
- SETD1A是HCC干和进展的关键表观遗传调节器.
- 准SETD1A为HCC干预提供了一个有前途的治疗策略.
更多相关视频
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
07:08Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
相关概念视频
Methods of Nuclear Reprogramming
Maintenance of the ES Cell State
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Somatic to iPS Cell Reprogramming
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal